Cytokinetics Inc. buy Wells Fargo & Company
Start price
07.05.26
/
50%
€63.48
Target price
07.05.27
€89.31
Performance (%)
3.65%
Price
22:25
€65.80
Summary
This prediction is currently active. With a performance of 3.65%, the BUY prediction by Wells_Fargo___Compan for Cytokinetics Inc. is trending in the right direction. This prediction currently runs until 07.05.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 1.463% | 1.463% |
| iShares Core DAX® | -1,59 % | 5,03 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % |
| iShares S&P 500 | -3,23 % | 0,47 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (CYTK) had its price target raised by Wells Fargo & Company from $95.00 to $105.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat